{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:16:57Z","timestamp":1791155817397,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01DE020835"],"award-info":[{"award-number":["R01DE020835"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.bone.2014.10.021","type":"journal-article","created":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T13:18:31Z","timestamp":1414761511000},"page":"201-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice"],"prefix":"10.1016","volume":"71","author":[{"given":"Teruhito","family":"Yoshitaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuho","family":"Kittaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyoshi","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyoshi","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2014.10.021_bb0005","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0278-2391(98)90618-8","article-title":"Treatment of cherubism with locally aggressive behavior presenting in adulthood: report of four cases and a proposed new grading system","volume":"56","author":"Kalantar Motamedi","year":"1998","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bone.2014.10.021_bb0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jcms.2004.07.006","article-title":"Cherubism\u2014new hypotheses on pathogenesis and therapeutic consequences","volume":"33","author":"Hyckel","year":"2005","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.bone.2014.10.021_bb0015","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.celrep.2014.08.023","article-title":"Enhanced TLR-MYD88 signaling stimulates autoinflammation in SH3BP2 cherubism mice and defines the etiology of cherubism","volume":"8","author":"Yoshitaka","year":"2014","journal-title":"Cell Reports"},{"key":"10.1016\/j.bone.2014.10.021_bb0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00002341-198906000-00010","article-title":"Cherubism and its orbital manifestations","volume":"5","author":"Hawes","year":"1989","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.bone.2014.10.021_bb0025","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/S0161-6420(01)00757-6","article-title":"Orbital involvement in cherubism","volume":"108","author":"Colombo","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.bone.2014.10.021_bb0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1442-9071.2001.00363.x","article-title":"Orbital involvement in cherubism","volume":"29","author":"Carroll","year":"2001","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.bone.2014.10.021_bb0035","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archopht.121.4.570","article-title":"Optic neuropathy and macular chorioretinal folds caused by orbital cherubism","volume":"121","author":"Ahmadi","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.bone.2014.10.021_bb0040","first-page":"573","article-title":"Cherubism and upper airway obstruction","volume":"122","author":"Battaglia","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.bone.2014.10.021_bb0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/88832","article-title":"Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism","volume":"28","author":"Ueki","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.bone.2014.10.021_bb0050","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1074-7613(00)80657-3","article-title":"Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation","volume":"9","author":"Deckert","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.bone.2014.10.021_bb0055","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1182\/blood-2003-08-2965","article-title":"The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor","volume":"105","author":"Foucault","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bone.2014.10.021_bb0060","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.4049\/jimmunol.166.12.7219","article-title":"Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2","volume":"166","author":"Jevremovic","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.bone.2014.10.021_bb0065","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1128\/MCB.00087-06","article-title":"3BP2 deficiency impairs the response of B cells, but not T cells, to antigen receptor ligation","volume":"26","author":"de la Fuente","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bone.2014.10.021_bb0070","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1128\/MCB.01014-06","article-title":"The 3BP2 adapter protein is required for optimal B-cell activation and thymus-independent type 2 humoral response","volume":"27","author":"Chen","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bone.2014.10.021_bb0075","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2011.10.045","article-title":"Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism","volume":"147","author":"Levaot","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bone.2014.10.021_bb0080","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.4049\/jimmunol.1103184","article-title":"The 3BP2 adapter protein is required for chemoattractant-mediated neutrophil activation","volume":"189","author":"Chen","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.bone.2014.10.021_bb0085","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.4049\/jimmunol.1200380","article-title":"The adaptor 3BP2 is required for early and late events in FcepsilonRI signaling in human mast cells","volume":"189","author":"Ainsua-Enrich","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.bone.2014.10.021_bb0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cell.2006.10.047","article-title":"Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 \u201ccherubism\u201d mice","volume":"128","author":"Ueki","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bone.2014.10.021_bb0095","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)","volume":"27","author":"Masters","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bone.2014.10.021_bb0100","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/jbmr.2125","article-title":"Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-\u03b1-induced inflammation and bone loss","volume":"29","author":"Yoshitaka","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.10.021_bb0105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.bone.2012.10.003","article-title":"Anti-tumor necrosis factor treatment in cherubism\u2014clinical, radiological and histological findings in two children","volume":"52","author":"Hero","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.10.021_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.2295","article-title":"SH3BP2 cherubism mutation potentiates TNF-alpha-induced osteoclastogenesis via NFATc1 and TNF-alpha-mediated inflammatory bone loss","author":"Mukai","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.10.021_bb0115","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0140-6736(97)09214-3","article-title":"Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Parties","volume":"351","author":"Burnett","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2014.10.021_bb0120","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2014.10.021_bb0125","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/j.bbmt.2009.09.013","article-title":"Aplastic anemia: pathophysiology and treatment","volume":"16","author":"Young","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bone.2014.10.021_bb0130","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2014.10.021_bb0135","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(81)91046-1","article-title":"Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation","volume":"2","author":"Hobbs","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2014.10.021_bb0140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00019052-199904000-00007","volume":"12","author":"Krivit","year":"1999","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.bone.2014.10.021_bb0145","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.bmt.1704105","article-title":"Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources","volume":"31","author":"Souillet","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bone.2014.10.021_bb0150","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0140-6736(68)92672-X","article-title":"Bone-marrow transplantation in a patient with the Wiskott\u2013Aldrich syndrome","volume":"2","author":"Bach","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2014.10.021_bb0155","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1182\/blood-2007-03-076679","article-title":"Long-term outcome following hematopoietic stem-cell transplantation in Wiskott\u2013Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation","volume":"111","author":"Ozsahin","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bone.2014.10.021_bb0160","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.joms.2006.02.003","article-title":"Cherubism: a clinical, radiographic, and histopathologic comparison of 7 cases","volume":"64","author":"Penarrocha","year":"2006","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bone.2014.10.021_bb0165","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.10.021_bb0170","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.bjoms.2006.08.013","article-title":"Cherubism: long-term follow-up of 2 patients in whom it regressed without treatment","volume":"45","author":"Silva","year":"2007","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.bone.2014.10.021_bb0175","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1067\/moe.2000.108438","article-title":"Cherubism: a 36-year long-term follow-up of 2 generations in different families and review of the literature","volume":"90","author":"Von Wowern","year":"2000","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2014.10.021_bb0180","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1750-1172-7-S1-S6","article-title":"Cherubism: best clinical practice","volume":"7","author":"Papadaki","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bone.2014.10.021_bb0185","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejmg.2012.12.008","article-title":"Characterization of a Norwegian cherubism cohort; molecular genetic findings, oral manifestations and quality of life","volume":"56","author":"Prescott","year":"2013","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.bone.2014.10.021_bb0190","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1054\/bjps.2001.3701","article-title":"Cherubism and its charlatans","volume":"54","author":"Lannon","year":"2001","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.bone.2014.10.021_bb0195","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bjoms.2005.10.003","article-title":"The aggressive form of cherubism: report of two cases in unrelated families","volume":"44","author":"Wang","year":"2006","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.bone.2014.10.021_bb0200","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ijporl.2007.01.017","article-title":"Aggressive case of cherubism: 17-year follow-up","volume":"71","author":"Pontes","year":"2007","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.bone.2014.10.021_bb0205","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.oraloncology.2007.01.012","article-title":"A novel mutation of the SH3BP2 gene in an aggressive case of cherubism","volume":"44","author":"Carvalho","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.bone.2014.10.021_bb0210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/2156-7514.93275","article-title":"Aggressive form of cherubism","volume":"2","author":"Reddy","year":"2012","journal-title":"J Clin Imaging Sci"},{"key":"10.1016\/j.bone.2014.10.021_bb0215","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/01.sap.0000248141.36904.19","article-title":"Two-stage surgical treatment of severe cherubism","volume":"58","author":"Raposo-Amaral","year":"2007","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.bone.2014.10.021_bb0220","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ijom.2004.09.006","article-title":"Clinicopathologic study of 24 cases of cherubism","volume":"34","author":"Meng","year":"2005","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.bone.2014.10.021_bb0225","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.immuni.2012.10.014","article-title":"Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly","volume":"37","author":"Kollmann","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.bone.2014.10.021_bb0230","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nri3547","article-title":"Age-dependent dysregulation of innate immunity","volume":"13","author":"Shaw","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bone.2014.10.021_bb0235","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.prosdent.2006.09.014","article-title":"A prosthetic treatment approach for a cherubism patient: a clinical report","volume":"96","author":"Yilmaz","year":"2006","journal-title":"J Prosthet Dent"},{"key":"10.1016\/j.bone.2014.10.021_bb0240","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.joms.2006.06.266","article-title":"Cherubism treated with calcitonin: report of a case","volume":"65","author":"de Lange","year":"2007","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bone.2014.10.021_bb0245","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-0039-1698923","article-title":"Treatment of cherubism with salmon calcitonin: a case report","volume":"5","author":"Etoz","year":"2011","journal-title":"Eur J Dent"},{"key":"10.1016\/j.bone.2014.10.021_bb0250","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/09546630410017275","article-title":"A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab","volume":"15","author":"Scheinfeld","year":"2004","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.bone.2014.10.021_bb0255","first-page":"147","article-title":"Ineffectiveness of tumor necrosis factor-alpha inhibition in association with bisphosphonates for the treatment of cherubism","volume":"29","author":"Pagnini","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.bone.2014.10.021_bb0260","doi-asserted-by":"crossref","first-page":"e105518","DOI":"10.1371\/journal.pone.0105518","article-title":"SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis model","volume":"9","author":"Mukai","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2014.10.021_bb0265","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bone.2010.01.380","article-title":"Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties","volume":"46","author":"Wang","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.10.021_bb0270","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bone.2014.10.021_bb0275","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2014.10.021_bb0280","first-page":"265","article-title":"Early infectious complications in autologous bone marrow transplantation: a review of 219 patients","volume":"18","author":"Mossad","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bone.2014.10.021_bb0285","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.bmt.1702849","article-title":"Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes","volume":"27","author":"Roy","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bone.2014.10.021_bb0290","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1182\/blood.V86.3.906.906","article-title":"A randomized trial comparing interferon-alpha with busulfan for newly diagnosed chronic myelogenous leukemia in chronic phase","volume":"86","author":"Ohnishi","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bone.2014.10.021_bb0295","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1182\/blood.V75.4.1011.1011","article-title":"Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation","volume":"75","author":"Holler","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bone.2014.10.021_bb0300","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1126\/science.1204094","article-title":"TAL effectors: customizable proteins for DNA targeting","volume":"333","author":"Bogdanove","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bone.2014.10.021_bb0305","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.bone.2014.10.021_bb0310","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bone.2014.10.021_bb0315","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-med-050311-163324","article-title":"Reprogrammed cells for disease modeling and regenerative medicine","volume":"64","author":"Cherry","year":"2013","journal-title":"Annu Rev Med"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214003949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214003949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T09:00:25Z","timestamp":1598432425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328214003949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":63,"alternative-id":["S8756328214003949"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2014.10.021","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2014.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}